The Chemours Co
CCBuild a strategy around CC
The Chemours Co AI Insights
Informational only. Not investment advice.Snapshot
- Debt/Equity of 14.8x with 269M TTM interest expense consuming 4.1x operating income - capital structure unsustainable at current profitability[Debt to Equity]
- Negative FCF TTM (-12M) despite 265M operating cash flow; 277M capex required just to maintain operations[Free Cash Flow TTM]
- Equity of 298M supports 7.6B in assets - 96% debt-funded; tangible book only 250M vs 1.9B market cap[Common Stockholders Equity]
Watch Triggers
- Interest Expense TTM: Exceeds EBITDA (currently 269M vs 422M) — Would signal imminent covenant breach or restructuring
- Cash and Equivalents: Falls below 400M (currently 613M) — Liquidity cushion eroding; may trigger credit facility draw
- Gross Margin TTM: Stabilizes above 20% for 2 quarters — First sign of pricing power recovery and turnaround potential
Bull Case
Asset turnover 0.78x (vs 0.19x median) shows operational efficiency; 3.4B PPE generates 5.8B revenue - potential value in hard assets if restructured
P/S 0.32x deeply discounted vs 4.1x median; EV/Revenue 0.97x prices in distress but not liquidation
Bear Case
Interest expense (269M) exceeds operating income (65M) by 4x - company cannot service debt from operations; refinancing risk acute
EPS declined 36% over 3yr and 17% YoY with negative net income (-320M TTM) - no earnings recovery visible
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage CC's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Interest burden likely forces dividend cut or asset sales within 12-18 months
- 269M interest vs 65M operating income TTM
- Negative FCF while paying 13M dividends
- 4.4B debt with only 613M cash
Gross margin compression (-18.5% YoY) signals pricing power erosion in specialty chemicals
- Gross margin fell to 17.5% TTM
- Cost of revenue 83% of sales
- Operating margin only 1.1%
Valuation Context
Caveats
Public Strategies Rankings
See how The Chemours Co ranks across different investment strategies.
Leverage CC's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
CC Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$3.25B | — | ||
$7.05B | — | ||
0.00 | — | ||
$5.84B | +1.5% | — | |
$-2.13 | — | ||
1.11% | -5.3% | — | |
-5.48% | -6.8% | — | |
$-12.0M | — | ||
-67.0% | -77.8% | — | |
Beta 5Y (Monthly) | unknown | — |
CC Dividend History
2026
$0.08752025
$0.51252024
$1.00002023
$1.00002022
$1.00002021
$1.00002020
$1.00002019
$1.00002018
$0.84002017
$0.12002016
$0.12002015
$0.5800CC Stock Splits
CC SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
11/06/25 | 09/30/25 | 10-Q | |
08/05/25 | 06/30/25 | 10-Q | |
05/06/25 | 03/31/25 | 10-Q | |
02/18/25 | 12/31/24 | Unknown | |
11/04/24 | 09/30/24 | 10-Q | |
08/01/24 | 06/30/24 | 10-Q | |
04/30/24 | 03/31/24 | 10-Q | |
03/27/24 | 12/31/23 | 10-K | |
10/27/23 | 09/30/23 | 10-Q | |
07/28/23 | 06/30/23 | 10-Q | |
04/28/23 | 03/31/23 | 10-Q | |
02/10/23 | 12/31/22 | 10-K | |
10/26/22 | 09/30/22 | 10-Q | |
08/01/22 | 06/30/22 | 10-Q | |
05/03/22 | 03/31/22 | 10-Q | |
02/11/22 | 12/31/21 | 10-K | |
11/05/21 | 09/30/21 | 10-Q | |
07/30/21 | 06/30/21 | 10-Q | |
05/05/21 | 03/31/21 | 10-Q | |
02/12/21 | 12/31/20 | 10-K | |
11/04/20 | 09/30/20 | 10-Q | |
07/31/20 | 06/30/20 | 10-Q | |
05/06/20 | 03/31/20 | 10-Q | |
02/14/20 | 12/31/19 | 10-K | |
11/05/19 | 09/30/19 | 10-Q | |
08/02/19 | 06/30/19 | 10-Q | |
05/03/19 | 03/31/19 | 10-Q | |
02/15/19 | 12/31/18 | 10-K | |
11/02/18 | 09/30/18 | 10-Q | |
08/03/18 | 06/30/18 | 10-Q | |
05/04/18 | 03/31/18 | 10-Q | |
02/16/18 | 12/31/17 | 10-K | |
11/03/17 | 09/30/17 | 10-Q | |
08/03/17 | 06/30/17 | 10-Q | |
05/03/17 | 03/31/17 | 10-Q | |
02/17/17 | 12/31/16 | 10-K | |
11/07/16 | 09/30/16 | 10-Q | |
08/09/16 | 06/30/16 | 10-Q | |
05/09/16 | 03/31/16 | 10-Q | |
02/25/16 | 12/31/15 | 10-K | |
11/05/15 | 09/30/15 | 10-Q | |
08/06/15 | 06/30/15 | 10-Q | |
06/05/15 | 03/31/15 | IPO-Q | |
06/05/15 | 12/31/14 | IPO-Q | |
02/12/15 | 09/30/14 | IPO-Q | |
08/07/15 | 06/30/14 | 10-Q/A | |
06/05/15 | 03/31/14 | IPO-Q | |
02/12/15 | 12/31/13 | IPO-Q |